GLP-1 Clinical Relevance #45Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Metabolic-Associated Steatotic Liver DiseaseNewsObservationalFatty Liver DiseaseInsulin ResistanceEndocrinologyAdults with ObesityHepatic OutcomesIncretin EffectType 2...
CBD Gummies and Fatty Liver: What the Evidence Shows and Practical Considerations
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic HepatologyCbdDrug SafetyMetabolic HealthLiver Function Why This MattersFatty liver disease affects over 100 million Americans,...
New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic NewResearchSuggestsCannabinoids Why This MattersThis item covers developments relevant to cannabis medicine and clinical practice....
Drugs inhibiting cannabinoid receptor type-1 can reduce obesity-associated steatohepatitis
Cannabinoid receptor type 1 antagonist inhibits progression of obesity‐associated nonalcoholic steatohepatitis in a mouse model by remodulating immune system disturbances In Summary: Steatohepatitis, a condition often associated with type 2 diabetes and...